Evidence map›Paper›PMID 34349104›Full record

ArticleNature communications2021

Reversible gene silencing through frameshift indels and frameshift scars provide adaptive plasticity for Mycobacterium tuberculosis.

Aditi Gupta, David Alland

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Impact of differentTranslational lung cancer research · 2026
    Article
  2. Journal of bacteriology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phase variation as a major mechanism of adaptation inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Features ofMicroorganisms · 2023
    Article
  11. Article
  12. Comparative Genome Analysis of 19Antibiotics (Basel, Switzerland) · 2022
    Article
  13. The rate and role of pseudogenes of theMicrobial genomics · 2022
    Article
  14. Article
  15. Review
  16. A critical evaluation ofMicrobial genomics · 2022
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aditi GuptaCenter for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ, USA. aditi9783@gmail.com.
David AllandCenter for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ, USA. david.alland@rutgers.edu.ORCID 0000-0001-5196-1571

Funding

Supercomputing: Rutgers' Catalyst for Discovery at the Frontiers of MedicineS10OD012346 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI MICHELSON, LESLIE PAUL · 2015 to 2015
$1.7M
NIH HHS S10 OD012346
6 · The paper itself

Abstract

Mycobacterium tuberculosis can adapt to changing environments by non-heritable mechanisms. Frame-shifting insertions and deletions (indels) may also participate in adaptation through gene disruption, which could be reversed by secondary introduction of a frame-restoring indel. We present ScarTrek, a program that scans genomic data for indels, including those that together disrupt and restore a gene's reading frame, producing "frame-shift scars" suggestive of reversible gene inactivation. We use ScarTrek to analyze 5977 clinical M. tuberculosis isolates. We show that indel frequency inversely correlates with genomic linguistic complexity and varies with gene-position and gene-essentiality. Using ScarTrek, we detect 74 unique frame-shift scars in 48 genes, with a 3.74% population-level incidence of unique scar events. We find multiple scars in the ESX-1 gene cluster. Six scars show evidence of convergent evolution while the rest shared a common ancestor. Our results suggest that sequential indels are a mechanism for reversible gene silencing and adaptation in M. tuberculosis.

Indexed as

Gene SilencingAdaptation, PhysiologicalEvolution, MolecularGenes, BacterialGenome, BacterialHumansINDEL MutationMycobacterium tuberculosisReading FramesTuberculosis

Identifiers

PMID34349104
PMCPMC8339072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.